Abiopharma

News list

WEISS ROBERT S 🟡 adjusted position in 3.8K shares (2 derivative) of COOPER COMPANIES, INC. (COO) Transaction Date: Apr 01, 2026 | Filing ID: 000001

Full text

News bot April 6, 2026, 9:17 p.m.
🔍 WEISS ROBERT S (Executive)

Company: COOPER COMPANIES, INC. (COO)

Report Date: 2026-04-01
Transaction Summary:
- Total transactions: 4
- Derivative instruments: 2
- Holdings reported: 1
- Total shares acquired: 7,433
- Total shares sold: 3,654
- Total shares held: 257,860
Detailed Transactions and Holdings:
- Acquired 3,654 shares of Common Stock (Direct)
  Date: 2026-04-01 | Code: M | equity_swap_involved: false | shares_owned_after: 292,599.00 | transaction_form_type: 4
- Holds 0 shares of Common Stock (Direct)
  Date: 2026-04-01 | Code: H | nature_of_ownership: see footnote | shares_owned_after: 257,860.00 | Footnotes: F1
- Sold 3,654 shares of Restricted Stock Units (Derivative)
  Date: 2026-04-01 | Code: M | Exercise: 2026-04-01 | equity_swap_involved: false | transaction_form_type: 4 | Footnotes: F2
- Acquired 3,779 shares of Restricted Stock Units (Derivative)
  Date: 2026-04-01 | Code: A | Exercise: 2027-04-01 | equity_swap_involved: false | shares_owned_after: 3,779.00 | transaction_form_type: 4 | Footnotes: F2
Footnotes:
- F1: Shares held by the Robert and Marilyn Weiss Trust dated 5/17/06, of which the Reporting Person and his spouse are co-trustees.
- F2: This award has no expiration date. Units will either vest or be forfeited.